The aim of this study was to assess the metabolic changes during development of esophageal adenocarcinoma by evaluating MCT1, MCT4 and mitochondrial cytochrome c oxidase (MTCO1) in different stages of esophageal metaplasia-dysplasia-adenocarcinoma-sequence. This evidence concerns the gene SLC16A1 and adenocarcinoma.